Endo to pay $830M to settle pelvic mesh lawsuits

Drug and medical device maker Endo International says it will pay $830 million to resolve roughly 20,000 personal lawsuits from patients who say they were injured by the company's vaginal mesh implants.

The Irish company said in a statement Wednesday that the settlement is subject to a number of conditions and is not an admission of liability.

Tens of thousands of have sued Endo and other device makers over mesh used to repair pelvic collapse in women. Mesh implants were initially pitched to doctors as an improvement over surgery, but the Food and Drug Administration has concluded they carry a higher risk of side effects including pain, and infection.

On Tuesday, the FDA proposed regulating vaginal mesh repair products as "high-risk" medical devices, subject to stricter safety requirements.

not rated yet
add to favorites email to friend print save as pdf

Related Stories

FDA wants stricter safety rules for pelvic mesh

Apr 29, 2014

Makers of trouble-prone implants used to surgically repair women's pelvic problems would be subject to stricter safety requirements under a federal proposal issued Tuesday.

Mesh doesn't up cure rate for vaginal prolapse repair

Sep 12, 2013

(HealthDay)—There are no differences in cure rates after three years of follow-up between women receiving mesh or no mesh for vaginal prolapse repair, according to a study published online Sept. 6 in Obstetrics & ...

Advocacy group seeks ban on pelvic surgical mesh

Aug 25, 2011

(AP) -- A consumer advocacy group is calling on government regulators to ban a type of surgical mesh used to treat pelvic collapse, saying it exposes patients to serious risks.

Recommended for you

New approach to particle therapy dosimetry

12 hours ago

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.